-
My Account
My Account
BSE Live
Apr 13, 16:00Prev. Close
6192.60
Open Price
6210.00
Bid Price (Qty.)
6190.75 (1)
Offer Price (Qty.)
6350.00 (2)
NSE Live
Apr 13, 15:58Prev. Close
6198.05
Open Price
6226.00
Bid Price (Qty.)
6229.00 (38)
Offer Price (Qty.)
0.00 (0)
| Half Yearly Results of Procter & Gamble Health (in Rs. Cr.) | Dec '20 | Dec '19 | Jun '19 | Dec '18 | Jun '18 | |
| Net Sales/Income from operations | 504.19 | 461.93 | 464.66 | 430.54 | 418.45 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 504.19 | 461.93 | 464.66 | 430.54 | 418.45 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 139.72 | 137.33 | 161.16 | 115.20 | 130.33 | |
| Purchase of Traded Goods | 9.42 | 9.16 | 9.74 | 12.82 | 14.49 | |
| Increase/Decrease in Stocks | 9.40 | 11.69 | -29.20 | 8.92 | -12.39 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 72.18 | 60.50 | 63.70 | 67.21 | 64.07 | |
| Depreciation | 15.21 | 8.33 | 8.83 | 8.95 | 11.40 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 106.62 | 144.34 | 154.60 | 152.85 | 148.13 | |
| P/L Before Other | 151.64 | 90.59 | 95.83 | 64.59 | 62.44 | |
| Other Income | 12.44 | 12.78 | 35.16 | 13.25 | 11.14 | |
| P/L Before Int. | 164.08 | 103.37 | 130.99 | 77.83 | 73.58 | |
| Interest | 0.43 | -- | -- | -- | -- | |
| P/L Before Exceptional Items & Tax | 163.65 | 103.37 | 130.99 | 77.83 | 73.58 | |
| Exceptional Items | -- | -- | -- | -- | 6.57 | |
| P/L Before Tax | 163.65 | 103.37 | 130.99 | 77.83 | 80.15 | |
| Tax | 36.51 | 29.40 | 46.20 | 23.23 | 33.01 | |
| P/L After Tax from Ordinary Activities | 127.14 | 73.97 | 84.79 | 54.60 | 47.13 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | 713.07 | 23.91 | |
| Net Profit/(Loss) For the Period | 127.14 | 73.97 | 84.79 | 767.67 | 71.05 | |
| Equity Share Capital | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 76.60 | 44.56 | 51.08 | 462.48 | 42.80 | |
| Diluted EPS | 76.60 | -- | 51.08 | -- | 42.80 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 76.60 | 44.56 | 51.08 | 462.48 | 42.80 | |
| Diluted EPS. | 76.60 | -- | 51.08 | -- | 42.80 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
01.04.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
12.03.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
09.03.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
25.02.2021
Procter&Gamble Standalone December 2020 Net Sales at Rs 240.22 crore, up 1.46% Y-o-Y
